Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints

Teva Pharmaceutical Industries (TEVA.TA), the world’s largest generic drugmaker, met fourth-quarter profit estimates, but its shares fell after its forecast of a largely flat year in 2023 disappointed investors.